Daniel Shevrin to Administration, Intravesical
This is a "connection" page, showing publications Daniel Shevrin has written about Administration, Intravesical.
Connection Strength
0.056
-
Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non-muscle-invasive Bladder Cancer (BRIDGE). Eur Urol Focus. 2023 07; 9(4):561-563.
Score: 0.056